6171 - 6180 of 6230 Results
Title
Year
-
OPENTitle: Targeting β-arrestin2 in the treatment ofl-DOPA–induced dyskinesia in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 112Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1502740112Best OA location URL: https://www.pnas.org/content/pnas/112/19/E2517.full.pdfCitation Count: 97
- A Failed Future2020OPENTitle: A Failed FutureJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1299End Page: 1301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28130Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28130Citation Count: 4
-
OPENTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3159957Citation Count: 81
-
OPENTitle: LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosisJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.51071Best OA location URL: https://cdn.elifesciences.org/articles/51071/elife-51071-v2.pdfCitation Count: 104
-
OPENTitle: Low‐variance RNAs identify Parkinson's disease molecular signature in bloodJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 6Start Page: 813End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26205Best OA location URL: http://doi.org/10.1002/mds.26205Citation Count: 18
-
OPENTitle: Scaling of an antibody validation procedure enables quantification of antibody performance in major research applicationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.91645Best OA location URL: https://cdn.elifesciences.org/articles/91645/elife-91645-v2.pdfCitation Count: 43
-
OPENTitle: Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET StudyJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 796End Page: 805Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29375Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29375Citation Count: 19
-
OPENTitle: Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and AnalogsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 1Start Page: 119End Page: 135Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00597Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10147382Citation Count: 46
-
OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Best OA location URL: https://doi.org/10.1002/mds.29902Citation Count: 16
-
OPENTitle: Pharmacological validation of TDO as a target for Parkinson’s diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 288Issue #: 14Start Page: 4311End Page: 4331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/febs.15721Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.15721Citation Count: 22